Long Noncoding RNA XIST Regulates MiR-137-EZH2 Axis to Promote Tumor Metastasis in Colorectal Cancer

Overview

Journal Oncol Res

Specialty Oncology

Date 2018 Mar 3

PMID 29495975

Citations 33

Authors

Xingxiang Liu

Lin Cui

Dong Hua

Affiliations

Soon will be listed here.

Abstract

We aimed to investigate the significant role of long noncoding RNA X inactive specific transcript (XIST) in regulating tumor metastasis in colorectal cancer (CRC), as well as its possible mechanism. Expression of lncRNA XIST in CRC tissues and CRC cells was detected. CRC cells were transfected with pc-XIST, blank control si-XIST, or si-control, and then the effects of lncRNA XIST on CRC cell migration and invasion were investigated, along with the interaction between lncRNA XIST and miR-137. lncRNA XIST was upregulated in CRC tissues. Compared with HT29 cells that had low metastatic potential, XIST was markedly more highly expressed in LoVo cells that had a higher metastatic potential. Overexpression of XIST promoted the migratory and invasive potential of HT29 cells, while knockdown of XIST inhibited the migratory and invasive potential of LoVo cells. Moreover, epithelial-mesenchymal transition (EMT) markers, including E-cadherin, N-cadherin, and vimentin, exhibited corresponding expression changes. In addition, miR-137 was inhibited by XIST, and inhibition of miR-137 could reverse the effects of knockdown of XIST on the migratory and invasive potential of LoVo cells. Furthermore, enhancer of zeste homolog 2 (EZH2) was confirmed as a target of miR-137. Our data reveal that lncRNA XIST may promote tumor metastasis in CRC possibly through regulating the miR-137-EZH2 axis. lncRNA XIST may serve as a prognostic indicator for CRC progression.

Citing Articles

Identification of MYC and STAT3 for early diagnosis based on the long noncoding RNA-mRNA network and bioinformatics in colorectal cancer.

Yao K, Fan H, Yang T, Yang C, Wang G, Li X Front Immunol. 2025; 15():1497919.

PMID: 39830506 PMC: 11739134. DOI: 10.3389/fimmu.2024.1497919.

Role of non-coding RNAs as new therapeutic targets in regulating the EMT and apoptosis in metastatic gastric and colorectal cancers.

Ebrahimi N, Hakimzadeh A, Bozorgmand F, Speed S, Manavi M, Khorram R Cell Cycle. 2023; 22(20):2302-2323.

PMID: 38009668 PMC: 10730205. DOI: 10.1080/15384101.2023.2286804.

The ceRNA network regulates epithelial-mesenchymal transition in colorectal cancer.

Li R, Xu H, Gao X Heliyon. 2023; 9(3):e14143.

PMID: 36950593 PMC: 10025087. DOI: 10.1016/j.heliyon.2023.e14143.

Comprehensive landscape and future perspectives of long noncoding RNAs (lncRNAs) in colorectal cancer (CRC): Based on a bibliometric analysis.

He J, Wu W Noncoding RNA Res. 2022; 8(1):33-52.

PMID: 36311994 PMC: 9582894. DOI: 10.1016/j.ncrna.2022.10.001.

Long noncoding RNA : Mechanisms for X chromosome inactivation, roles in sex-biased diseases, and therapeutic opportunities.

Li J, Ming Z, Yang L, Wang T, Liu G, Ma Q Genes Dis. 2022; 9(6):1478-1492.

PMID: 36157489 PMC: 9485286. DOI: 10.1016/j.gendis.2022.04.007.

References

Chang T, Tsai M, Gow C, Wu S, Liu Y, Chang Y . Upregulation of microRNA-137 expression by Slug promotes tumor invasion and metastasis of non-small cell lung cancer cells through suppression of TFAP2C. Cancer Lett. 2017; 402:190-202. DOI: 10.1016/j.canlet.2017.06.002. View

Grothey A, Van Cutsem E, Sobrero A, Siena S, Falcone A, Ychou M . Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial. Lancet. 2012; 381(9863):303-12. DOI: 10.1016/S0140-6736(12)61900-X. View

Wang H, Shen Q, Zhang X, Yang C, Cui S, Sun Y . The Long Non-Coding RNA XIST Controls Non-Small Cell Lung Cancer Proliferation and Invasion by Modulating miR-186-5p. Cell Physiol Biochem. 2017; 41(6):2221-2229. DOI: 10.1159/000475637. View

Siegel R, Miller K, Fedewa S, Ahnen D, Meester R, Barzi A . Colorectal cancer statistics, 2017. CA Cancer J Clin. 2017; 67(3):177-193. DOI: 10.3322/caac.21395. View

Thiery J, Acloque H, Huang R, Nieto M . Epithelial-mesenchymal transitions in development and disease. Cell. 2009; 139(5):871-90. DOI: 10.1016/j.cell.2009.11.007. View

Ma L, Zhou Y, Luo X, Gao H, Deng X, Jiang Y . Long non-coding RNA XIST promotes cell growth and invasion through regulating miR-497/MACC1 axis in gastric cancer. Oncotarget. 2016; 8(3):4125-4135. PMC: 5354817. DOI: 10.18632/oncotarget.13670. View

Dong P, Xiong Y, Watari H, Hanley S, Konno Y, Ihira K . MiR-137 and miR-34a directly target Snail and inhibit EMT, invasion and sphere-forming ability of ovarian cancer cells. J Exp Clin Cancer Res. 2016; 35(1):132. PMC: 5011787. DOI: 10.1186/s13046-016-0415-y. View

Svoboda M, Slyskova J, Schneiderova M, Makovicky P, Bielik L, Levy M . HOTAIR long non-coding RNA is a negative prognostic factor not only in primary tumors, but also in the blood of colorectal cancer patients. Carcinogenesis. 2014; 35(7):1510-5. DOI: 10.1093/carcin/bgu055. View

Xiong Y, Wang L, Li Y, Chen M, He W, Qi L . The Long Non-Coding RNA XIST Interacted with MiR-124 to Modulate Bladder Cancer Growth, Invasion and Migration by Targeting Androgen Receptor (AR). Cell Physiol Biochem. 2017; 43(1):405-418. DOI: 10.1159/000480419. View

10.

Yu H, Xue Y, Wang P, Liu X, Ma J, Zheng J . Knockdown of long non-coding RNA XIST increases blood-tumor barrier permeability and inhibits glioma angiogenesis by targeting miR-137. Oncogenesis. 2017; 6(3):e303. PMC: 5533948. DOI: 10.1038/oncsis.2017.7. View

11.

Pritchard C, Grady W . Colorectal cancer molecular biology moves into clinical practice. Gut. 2010; 60(1):116-29. PMC: 3006043. DOI: 10.1136/gut.2009.206250. View

12.

Qi P, Du X . The long non-coding RNAs, a new cancer diagnostic and therapeutic gold mine. Mod Pathol. 2012; 26(2):155-65. DOI: 10.1038/modpathol.2012.160. View

13.

Fatica A, Bozzoni I . Long non-coding RNAs: new players in cell differentiation and development. Nat Rev Genet. 2013; 15(1):7-21. DOI: 10.1038/nrg3606. View

14.

Miller K, Siegel R, Lin C, Mariotto A, Kramer J, Rowland J . Cancer treatment and survivorship statistics, 2016. CA Cancer J Clin. 2016; 66(4):271-89. DOI: 10.3322/caac.21349. View

15.

Sun J, Ding C, Yang Z, Liu T, Zhang X, Zhao C . The long non-coding RNA TUG1 indicates a poor prognosis for colorectal cancer and promotes metastasis by affecting epithelial-mesenchymal transition. J Transl Med. 2016; 14:42. PMC: 4745176. DOI: 10.1186/s12967-016-0786-z. View

16.

Sakaguchi M, Hisamori S, Oshima N, Sato F, Shimono Y, Sakai Y . miR-137 Regulates the Tumorigenicity of Colon Cancer Stem Cells through the Inhibition of DCLK1. Mol Cancer Res. 2016; 14(4):354-62. DOI: 10.1158/1541-7786.MCR-15-0380. View

17.

Li W, Zhang G, Wang H, Wang L . Analysis of expression of cyclin E, p27kip1 and Ki67 protein in colorectal cancer tissues and its value for diagnosis, treatment and prognosis of disease. Eur Rev Med Pharmacol Sci. 2016; 20(23):4874-4879. View

18.

Liu L, Lu S, Li M, Li L, Fu J, Hu W . FoxD3-regulated microRNA-137 suppresses tumour growth and metastasis in human hepatocellular carcinoma by targeting AKT2. Oncotarget. 2014; 5(13):5113-24. PMC: 4148126. DOI: 10.18632/oncotarget.2089. View

19.

Ji Q, Zhang L, Liu X, Zhou L, Wang W, Han Z . Long non-coding RNA MALAT1 promotes tumour growth and metastasis in colorectal cancer through binding to SFPQ and releasing oncogene PTBP2 from SFPQ/PTBP2 complex. Br J Cancer. 2014; 111(4):736-48. PMC: 4134507. DOI: 10.1038/bjc.2014.383. View

20.

Song P, Ye L, Zhang C, Peng T, Zhou X . Long non-coding RNA XIST exerts oncogenic functions in human nasopharyngeal carcinoma by targeting miR-34a-5p. Gene. 2016; 592(1):8-14. DOI: 10.1016/j.gene.2016.07.055. View